Market Overview

Sage Therapeutics (NASDAQ: SAGE)

172.72 -3.15 (-1.79%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/17/17BMO CapitalMaintainsOutperform112.0
11/16/17Bank of AmericaMaintainsBuy101.0
11/13/17Canaccord GenuityMaintainsBuy140.0
11/10/17Chardan CapitalUpgradesBuy0.0
9/15/17RBC CapitalInitiates Coverage OnOutperform117.0
9/14/17BMO CapitalMaintainsOutperform80.0
9/13/17Canaccord GenuityMaintainsBuy81.0
8/09/17Stifel NicolausInitiates Coverage OnBuy104.0
5/16/17NeedhamInitiates Coverage OnBuy82.0
2/22/17H.C. WainwrightDowngradesNeutral0.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter